Skip to content

SPECTRUM PHARMACEUTICALS INC

Delisted

CIK 831547fmd_1S42HHC2RSD28S9JKV5KYYR93SManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Mar 31, 2023, 53 periods

Latest annual · FY2022

Millions
Total revenues
10
Gross profit
(4)
Operating income
(73)
Net income
(75)
Free cash flow
(97)

Latest quarter · Q1 FY2023

Millions
Total revenues
16
Operating income
(5)
Net income
(5)
Free cash flow
(22)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
n/m
Revenue, 5 yearsFY2017 to FY2022
n/m
Net income, 5 yearsFY2017 to FY2022
n/m

SPECTRUM PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$10.1 million$010-K 2023-03-31 · proof
Operating income-$72.7 million-$147.7 million10-K 2023-03-31 · proof
Net income-$75.4 million-$158.6 million10-K 2023-03-31 · proof
Cash from operating activities-$97 million-$119.5 million10-K 2023-03-31 · proof
Free cash flow-$97.3 million-$119.7 million10-K 2023-03-31 · proof
Total assets$103.3 million$111.5 million-7.4%10-K 2023-03-31 · proof
Total liabilities$75.5 million$64 million+17.9%10-K 2023-03-31 · proof
Cash and cash equivalents$40.4 million$88.5 million-54.4%10-K 2023-03-31 · proof
What was SPECTRUM PHARMACEUTICALS INC's revenue in fiscal 2022?
SPECTRUM PHARMACEUTICALS INC reported revenue of $10.1 million for fiscal 2022 (the year ended Dec 31, 2022), against $0 the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
What was SPECTRUM PHARMACEUTICALS INC's operating income in fiscal 2022?
SPECTRUM PHARMACEUTICALS INC reported operating income of -$72.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$147.7 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
What was SPECTRUM PHARMACEUTICALS INC's net income in fiscal 2022?
SPECTRUM PHARMACEUTICALS INC reported net income of -$75.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$158.6 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
What was SPECTRUM PHARMACEUTICALS INC's cash from operating activities in fiscal 2022?
SPECTRUM PHARMACEUTICALS INC reported cash from operating activities of -$97 million for fiscal 2022 (the year ended Dec 31, 2022), against -$119.5 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
What was SPECTRUM PHARMACEUTICALS INC's free cash flow in fiscal 2022?
SPECTRUM PHARMACEUTICALS INC reported free cash flow of -$97.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$119.7 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
What are SPECTRUM PHARMACEUTICALS INC's total assets?
As of Dec 31, 2022, SPECTRUM PHARMACEUTICALS INC reported total assets of $103.3 million, against $111.5 million a year earlier (-7.4%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
What are SPECTRUM PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2022, SPECTRUM PHARMACEUTICALS INC reported total liabilities of $75.5 million, against $64 million a year earlier (+17.9%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
What are SPECTRUM PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2022, SPECTRUM PHARMACEUTICALS INC reported cash and cash equivalents of $40.4 million, against $88.5 million a year earlier (-54.4%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:831547&period_type=annual&limit=5"

Information only, not investment advice.